# BENZONATATE

NDC: 67877-575
Generic name: BENZONATATE
Labeler / Manufacturer: Ascend Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20170322

FDA application: ANDA040627

## Active ingredients

- BENZONATATE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67877-575"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67877-575
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=54374c04-63b9-49fa-b6a2-4a711e322d8e